HALO Macrodissection Solutions: Enhancing the Accuracy of Personalized...
From Pathology News: Analyzing the genetic content of cancer is an important step for accurate prognostication and treatment of affected patients. Tumor genetic testing is becoming increasingly more...
View ArticleRevolutionizing ROSE (Rapid On-Site Evaluation)
Mark Clymer of Accu-Scope sat down for an interview with Hari Subramanian from ASP Healthcare. They explored the challenges of the current ROSE process and provide one avenue of solutions that...
View ArticleProscia: Georgia Tech Honors Proscia’s Nathan Buchbinder With 2025 College Of...
Co-founder and Chief strategy officer recognized for establishing Proscia as a market leader PHILADELPHIA – March 10, 2025 – The Georgia Institute of Technology’s College of Engineering has named...
View ArticleDiagnexia and Stratipath link up brings AI breast cancer diagnostics to UK
Diagnexia and Stratipath: Collaboration expands AI-based risk profiling tools Diagnexia has announced a partnership with Stratipath AB to bring Stratipath Breast, an AI-based prognostic risk profiling...
View ArticleCheers to USCAP 2025: Recapping The Momentum, Insights, and Inspiration
The United States and Canadian Academy of Pathology (USCAP) Annual Meeting is always a standout—a forum for trading the latest insights, engaging with the Concentriq community, and enjoying time with...
View ArticleFortis Healthcare launches Fortis Institute of Genomic Medicine
Fortis: The institute will bring together a team of medical experts, including molecular hematology, oncology, neurology, paediatrics, pathology, and genomic scientists along with bioinformaticians and...
View Article